Valneva SE (VALN)
6.72
+0.04
(+0.60%)
USD |
NASDAQ |
Sep 10, 15:22
Valneva EPS Diluted (Quarterly) : -0.3826 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3826 |
| March 31, 2026 | -0.4361 |
| December 31, 2025 | -0.6714 |
| September 30, 2025 | -0.6037 |
| June 30, 2025 | -0.1617 |
| March 31, 2025 | -0.1197 |
| December 31, 2024 | -0.4859 |
| September 30, 2024 | -0.1251 |
| June 30, 2024 | -0.3868 |
| March 31, 2024 | 0.9214 |
| December 31, 2023 | -0.4984 |
| September 30, 2023 | -0.5365 |
| June 30, 2023 | -0.2654 |
| March 31, 2023 | -0.2814 |
| December 31, 2022 | -0.6524 |
| September 30, 2022 | 1.244 |
| June 30, 2022 | -2.848 |
| March 31, 2022 | -0.5429 |
| December 31, 2021 | 3.909 |
| September 30, 2021 | -3.765 |
| June 30, 2021 | -1.465 |
| March 31, 2021 | -0.7285 |
| December 31, 2020 | -0.0541 |
| September 30, 2020 | -0.9434 |
| June 30, 2020 | -0.5925 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0295 |
| December 31, 2019 | 0.0166 |
| September 30, 2019 | -0.0008 |
| June 30, 2019 | -0.1774 |
| March 31, 2019 | 0.1135 |
| December 31, 2018 | 0.1618 |
| September 30, 2018 | -0.0906 |
| June 30, 2018 | -0.0501 |
| March 31, 2018 | 0.0456 |
| December 31, 2017 | -0.1177 |
| September 30, 2017 | -0.0947 |
| June 30, 2017 | -0.0671 |
| March 31, 2017 | -0.0428 |
| December 31, 2016 | -0.0642 |
| September 30, 2016 | -0.2013 |
| June 30, 2016 | -1.011 |
| March 31, 2016 | -0.1544 |
| December 31, 2015 | -0.0219 |
| September 30, 2015 | -0.1559 |
| June 30, 2015 | -0.2665 |
| March 31, 2015 | -0.1551 |
| December 31, 2014 | -0.446 |
| September 30, 2014 | -0.0942 |
| June 30, 2014 | -0.2229 |
| March 31, 2014 | -0.2963 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.0435 |
| Nicox SA | -- |
| DBV Technologies SA | -0.5804 |
| Cellectis SA | -0.2165 |
| Genfit SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.28M |
| Revenue (Quarterly) | 40.62M |
| Total Expenses (Quarterly) | 76.90M |
| Enterprise Value | 734.84M |
| Gross Profit Margin (Quarterly) | 4.58% |
| Profit Margin (Quarterly) | -89.31% |
| Earnings Yield | -31.16% |
| Normalized Earnings Yield | -31.16 |